ConductScience.org, home

Paper6574828

A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography.

Bolanowska W and 2 others. Cancer Chemother Pharmacol, 1983. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography. Papers, record 6574828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6574828

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1983
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
2.06
iCite
Revised in PubMed
2019-08-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bolanowska WW
2Gessner TT
3Preisler HH

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chromatography, High Pressure LiquidMajor topic
DaunorubicinMajor topic
DoxorubicinMajor topic
Leukemia, Myeloid, AcuteMajor topic
Humans

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA-13038NCI NIH HHSUnited StatesP01CA013038PubMed and NIHNIH RePORTER
CA-21071NCI NIH HHSUnited StatesP01CA021071PubMed and NIHNIH RePORTER
CA-24538NCI NIH HHSUnited StatesP30CA024538PubMed and NIHNIH RePORTER

Download CSV of grants

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1942583Clinical effects and pharmacokinetics of different dosage schedules of adriamycin.Cancer Res1976https://conductscience.org/library/papers/942583PubMed
2541422Measurement of adriamycin (doxorubicin) and its metabolites in human plasma using reversed-phase high-performance liquid chromatography and fluorescence detection.J Chromatogr1979https://conductscience.org/library/papers/541422PubMed
36104578Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.Drug Metab Dispos1980https://conductscience.org/library/papers/6104578PubMed
45527015Tissue distribution and disposition of daunomycin (NCS-82151) in mice: fluorometric and isotopic methods.Cancer Chemother Rep1970https://conductscience.org/library/papers/5527015PubMed
54723268Pharmacokinetics and metabolism of adriamycin in man.Clin Pharmacol Ther1973https://conductscience.org/library/papers/4723268PubMed
6659557Liquid chromatographic determination of daunorubicin and daunorubicinol in plasma from leukemic patients.J Chromatogr1978https://conductscience.org/library/papers/659557PubMed
7835599Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases.Am J Med1977https://conductscience.org/library/papers/835599PubMed
84512953Daunorubicin in the therapy of acute granulocytic leukemia.Cancer Res1973https://conductscience.org/library/papers/4512953PubMed
9795537Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity.Cancer Treat Rep1976https://conductscience.org/library/papers/795537PubMed
106459335Rapid high-performance liquid chromatographic assay for the anthracyclines daunorubicin and 7-con-O-methylnogarol in plasma.J Chromatogr1981https://conductscience.org/library/papers/6459335PubMed
11541423Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol.J Chromatogr1979https://conductscience.org/library/papers/541423PubMed
124290058Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia.Cancer1967https://conductscience.org/library/papers/4290058PubMed
13548536Quantitative thin-layer chromatography: thin-film fluorescence scanning analysis of adriamycin and metabolites in tissue.J Chromatogr1979https://conductscience.org/library/papers/548536PubMed
14649731Reversed-phase liquid chromatography of adriamycin and daunorubicin and their hydroxyl metabolites adriamycinol and daunorubicinol.J Chromatogr1978https://conductscience.org/library/papers/649731PubMed
156930988Determination of daunorubicin and its main metabolites in plasma, urine and leukaemic cells in patients with acute myeloblastic leukaemia.Cancer Lett1980https://conductscience.org/library/papers/6930988PubMed
16856462Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.Cancer Res1977https://conductscience.org/library/papers/856462PubMed
176927044Simplified toxicologic monitoring of adriamycin, its major metabolites and nogalamycin by reverse-phase high pressure liquid chromatography, Part I: Analytical techniques for isolated human plasma.J Anal Toxicol1980https://conductscience.org/library/papers/6927044PubMed
181107570Adriamycin-a review.J Natl Cancer Inst1975https://conductscience.org/library/papers/1107570PubMed
197090422Body residue and metabolism of adriamycin and daunorubicin in control and phenobarbital-pretreated mice.Xenobiotica1982https://conductscience.org/library/papers/7090422PubMed
204277990Adriamycin cardiotoxicity in man.Ann Intern Med1974https://conductscience.org/library/papers/4277990PubMed

See all 25 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
33195033A DNA Based Biosensor Amplified With ZIF-8/Ionic Liquid Composite for Determination of Mitoxantrone Anticancer Drug: An Experimental/Docking Investigation.Front Chem2020https://conductscience.org/library/papers/33195033PubMed
6697426Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6697426PubMed
3600054Plasma levels of daunorubicin metabolites and the outcome of ANLL therapy.Med Oncol Tumor Pharmacother1987https://conductscience.org/library/papers/3600054PubMed
3520474Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.Pharm Weekbl Sci1986https://conductscience.org/library/papers/3520474PubMed
3106964Coinduction of glucose-regulated proteins and doxorubicin resistance in Chinese hamster cells.Proc Natl Acad Sci U S A1987https://conductscience.org/library/papers/3106964PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6574828

GET https://conductscience.org/api/papers/v1/6574828/references?page=2